High Human Renin Hypertension in Transgenic Rats

Author:

Bohlender Jürgen1,Fukamizu Akiyoshi1,Lippoldt Andrea1,Nomura Tatsuji1,Dietz Rainer1,Ménard Joel1,Murakami Kazuo1,Luft Friedrich C.1,Ganten Detlev1

Affiliation:

1. From the Franz Volhard Clinic and the Max Delbrück Center for Molecular Medicine, Virchow Klinikum, Humboldt University of Berlin (J.B., A.L., R.D., F.C.L.); Department of Clinical Pharmacology, Klinikum Benjamin Franklin, Free University of Berlin (D.G.) (Germany); Central Institute for Laboratory Animals, Kanagawa, Japan (T.N.); Institut National de la Santé et de la Recherche Médicale (INSERM) U 367, Paris, France (J.M.); and University of Tsukuba, Ibaraki, Japan (A.F., K.M.).

Abstract

We developed a model of spontaneously high human renin hypertension in the rat by producing two transgenic strains, one for human angiotensinogen with the endogenous promoter and one for human renin with the endogenous promoter. Neither transgenic strain was hypertensive. These strains were then crossed, producing a double transgenic strain. The double transgenic rats, both males and females, developed severe hypertension (mean systolic pressure, 200 mm Hg) and died after a mean of 55 days if untreated. The rats had a human plasma renin concentration of 269±381 (±SD) ng angiotensin I (Ang I)/mL per hour, plasma renin activity of 177±176 ng Ang I/mL per hour, rat angiotensinogen concentration of 1.49±1 μg Ang I/mL, and human angiotensinogen concentration of 78±39 μg Ang I/mL (n=49). Control rats had plasma renin activity of 3.7±3.9 ng Ang I/mL per hour and rat angiotensinogen of 1.32±0.16 μg Ang I/mL. Angiotensinogen transgene expression by RNase protection assay was ubiquitously present but most prominent in liver. Renin transgene expression was high in kidney but absent in liver. The rats featured severe cardiac hypertrophy, with increased cross section of cardiomyocytes but little myocardial fibrosis. The kidneys showed atrophic tubules, thickened vessel walls, and increased interstitium. Both the angiotensin-converting enzyme inhibitor lisinopril and the specific human renin inhibitor remikiren lowered blood pressure to normal values. Double transgenic mice have been developed that exhibit features quite similar to those described here; their gene expressions are similar. The specificity of rodent and human renin is similarly documented. Although many elegant physiological studies can now be done in mice, rats nevertheless offer flexibility, particularly in terms of detailed cardiac and renal physiology and pharmacology. We conclude that this double transgenic strain will facilitate simultaneous investigation of genetic and pathophysiological aspects of renin-induced hypertension. The fact that human renin can be studied in the rat is a unique feature of this model.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Internal Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3